It is also priced at a discount to VXGN's net cash and liquidation values, and payment is to be made in
the watered scrip of OXGN, a speculative biotech play (see our more detailed take on the terms of the VXGN / OXGN deal).
Priced at a discount to VXGN's net cash and liquidation values, and payment in
the watered scrip of a speculative biotech play, it's a real dud for VXGN shareholders (see our more detailed take on the terms of the VXGN / OXGN deal).
Not exact matches
Silver suggested that if the state would be wading into very dangerous
waters if it gets into a «
scrip» situation, essentially asking banks to accept its IOUS and endangering its credit rating in the process.